skip to content
Drug wars : how big pharma raises prices and keeps generics off the market Preview this item
ClosePreview this item

Drug wars : how big pharma raises prices and keeps generics off the market

Author: Robin Feldman
Publisher: New York, NY : Cambridge University Press, 2017.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Summary:
In this book, Feldman and Frondorf explain how companies employ strategies that block generic medicines from the market and keep prices high.
You are not connected to the UC Merced Library network. Access to online content and services may require you to authenticate with your library. Off-Campus Access
Getting this item's online copy... Getting this item's online copy...

Find a copy in the library

Getting this item's location and availability... Getting this item's location and availability...

WorldCat

Find it in libraries globally
Worldwide libraries own this item

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Feldman, Robin
Drug Wars : How Big Pharma Raises Prices and Keeps Generics off the Market
New York : Cambridge University Press,c2017
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Robin Feldman
ISBN: 131675300X 9781316753002 9781316754931 1316754936 9781316749142 1316749142 9781316717424 1316717429
OCLC Number: 993686799
Description: 1 online resource ()
Contents: Cover; Half-title; Title page; Copyright information; Dedication; Table of contents; List of table and figures; Acknowledgments; Prologue; A Pharma under Fire; B A Note before We Begin; C The Strange Economics of Pharmaceuticals; D Generics --
a Brief Primer; Introduction; 1 "Generation 1.0"; A The Basic Contours of Pay-for-Delay; B Pay-for-Delay as a Bottleneck to Entry; C Is Pay-for-Delay Actually Wrong? Pharma Heads to the Supreme Court; 2 "Generation 2.0"; A Already Steps Ahead of Actavis; B In re Lipitor: Everything but the Kitchen Sink C The Post-Actavis Landscape, Contract Clauses, and King Drug3 "Generation 3.0"; A A New Generation of Pharmaceutical Delay; B Product Hopping and the Purple Pill; C New Examples of Product Hopping; D Scout's Honor in Product Hopping; 4 "Generation 3.0"; A REMS-Based Delay; B Delay via Citizen Petition; C Preventing the "Skinny Label": Blocking Carve-Outs; 5 Empirical Evidence of a Citizen's Pathway Gone Astray; A Methodology; 1 Overview; 2 Compiling All Citizen Petitions from 2000 to 2012; 3 Identifying Citizen Petitions That Could Delay Generic Competition 4 Timing of the Citizen Petitions Relative to Generic Applicationsi Filing Dates for Generic Applications; ii Matching Citizen Petitions to Relevant Applications; iii Establishing Key Metrics; B Results; 1 Rise in Citizen Petitions with the Potential to Delay; 2 When Are Citizen Petitions Filed in Relation to Final Approval?; 3 How Did the 2007 Amendments Affect Citizen Petition Timing?; 4 Did the 2007 Amendments Do the Job?; C The Road Ahead; 1 A Simple Prohibition; 2 Procedural Blocks; 3 Punitive Deterrents; 4 Transparency; Conclusion; A Societal Harms
Responsibility: Robin Feldman, Evan Frondorf.
Local System Bib Number:
999728702
cis38481990

Abstract:

In this book, Feldman and Frondorf explain how companies employ strategies that block generic medicines from the market and keep prices high.
Retrieving notes about this item Retrieving notes about this item

Reviews

User-contributed reviews

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.